Systematic review and metaanalysis of acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam DA Hammond, MN Smith, C Li, SM Hayes, K Lusardi, PB Bookstaver Clinical Infectious Diseases 64 (5), 666-674, 2017 | 194 | 2017 |
Comparative incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin‐tazobactam or cefepime: a retrospective cohort study DA Hammond, MN Smith, JT Painter, NK Meena, K Lusardi Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (5 …, 2016 | 95 | 2016 |
Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis DA Hammond, SW Lam, MA Rech, MN Smith, J Westrick, AP Trivedi, ... Annals of Pharmacotherapy 54 (1), 5-13, 2020 | 85 | 2020 |
Propofol for treatment of refractory alcohol withdrawal syndrome: a review of the literature AL Brotherton, EP Hamilton, HG Kloss, DA Hammond Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (4 …, 2016 | 71 | 2016 |
Evaluation of medication errors at the transition of care from an ICU to non-ICU location AP Tully, DA Hammond, C Li, AS Jarrell, RM Kruer Critical Care Medicine 47 (4), 543-549, 2019 | 67 | 2019 |
Prospective open‐label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock DA Hammond, OA Ficek, JT Painter, K McCain, J Cullen, AL Brotherton, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (5 …, 2018 | 65 | 2018 |
The 2016 ACCP pharmacotherapy didactic curriculum toolkit TL Schwinghammer, AJ Crannage, EG Boyce, B Bradley, A Christensen, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (11 …, 2016 | 61 | 2016 |
Grit: An important characteristic in learners DA Hammond Currents in Pharmacy Teaching and Learning 9 (1), 1-3, 2017 | 54 | 2017 |
Scoping review of interventions associated with cost avoidance able to be performed in the intensive care unit and emergency department DA Hammond, PK Gurnani, AH Flannery, KS Smetana, JC Westrick, I Lat, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (3 …, 2019 | 48 | 2019 |
Patient outcomes associated with phenobarbital use with or without benzodiazepines for alcohol withdrawal syndrome: a systematic review DA Hammond, JM Rowe, A Wong, TL Wiley, KC Lee, SL Kane-Gill Hospital pharmacy 52 (9), 607-616, 2017 | 46 | 2017 |
Evaluation of vasopressor exposure and mortality in patients with septic shock RJ Roberts, TA Miano, DA Hammond, GP Patel, JT Chen, KM Phillips, ... Critical care medicine 48 (10), 1445-1453, 2020 | 44 | 2020 |
Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia MN Smith, AL Brotherton, K Lusardi, CA Tan, DA Hammond Annals of Pharmacotherapy 53 (6), 627-638, 2019 | 44 | 2019 |
Efficacy and safety of the early addition of vasopressin to norepinephrine in septic shock DA Hammond, J Cullen, JT Painter, K McCain, OA Clem, AL Brotherton, ... Journal of Intensive Care Medicine 34 (11-12), 910-916, 2019 | 43 | 2019 |
Incidence of acute kidney injury among patients receiving the combination of vancomycin with piperacillin‐tazobactam or meropenem AD Robertson, C Li, DA Hammond, TA Dickey Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (12 …, 2018 | 43 | 2018 |
Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit MS Buckley, NC Hartsock, AJ Berry, DS Bikin, EC Richards, ... Journal of critical care 48, 32-38, 2018 | 40 | 2018 |
Short-course of ranolazine prevents postoperative atrial fibrillation following coronary artery bypass grafting and valve surgeries DA Hammond, C Smotherman, CA Jankowski, S Tan, O Osian, ... Clinical Research in Cardiology 104, 410-417, 2015 | 38 | 2015 |
Discontinuation of vasopressin before norepinephrine in the recovery phase of septic shock DA Hammond, K McCain, JT Painter, OA Clem, J Cullen, AL Brotherton, ... Journal of Intensive Care Medicine 34 (10), 805-810, 2019 | 37 | 2019 |
Pharmacist avoidance or reductions in medical costs in critically ill adults: PHARM-CRIT study MA Rech, PK Gurnani, WJ Peppard, KS Smetana, MA Van Berkel, ... Critical care explorations 3 (12), e0594, 2021 | 34 | 2021 |
PHarmacist avoidance or reductions in medical costs in patients presenting the EMergency department: PHARM-EM study MA Rech, W Adams, KS Smetana, PK Gurnani, MAVB Patel, WJ Peppard, ... Critical Care Explorations 3 (4), e0406, 2021 | 33 | 2021 |
Cost‐Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients DA Hammond, N Kathe, A Shah, BC Martin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (1 …, 2017 | 33 | 2017 |